XML 47 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' DEFICIT (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Stock Options Outstanding and Stock Option Activity
The following table presents a summary of the Company's stock options outstanding at and stock option activity during the year ended December 31, 2024 ("Price" reflects the weighted average exercise price per share):
(In thousands, except per share data)OptionsPriceWeighted
Average
Remaining
Contractual Term
Outstanding, January 1, 20247,188 $16.22 3.0 years
Granted— 
Exercised— 
Forfeited(10)13.13 
Expired(208)16.56 
Outstanding, December 31, 20246,970 16.21 2.1 years
Exercisable6,901 16.18 2.0 years
Expected to Vest69 19.36 6.3 years
Summary of Unvested Options and Changes
A summary of the Company's unvested options and changes during the year ended December 31, 2024 is presented below:
(In thousands, except per share data)OptionsWeighted Average Grant Date Fair Value
Unvested, January 1, 2024639 $5.99 
Granted— 
Vested(1)
(559)5.44 
Forfeited(11)6.76 
Unvested, December 31, 202469 10.37 
(1)The total fair value of the options vested during the year ended December 31, 2024 was $3.0 million.
Summary of Restricted Stock Outstanding and Restricted Stock Activity
The following table presents a summary of the Company's RSUs outstanding and RSU activity as of and during the year ended December 31, 2024 (“Price” reflects the weighted average share price at the date of grant):
(In thousands, except per share data)AwardsPrice
Outstanding, January 1, 202411,611 $6.48 
Granted4,863 2.08 
Vested (restriction lapsed)(3,051)6.07 
Forfeited(362)5.90 
Outstanding, December 31, 202413,061 4.95 
Schedule of Share-Based Payment Arrangement, Cost by Plan
The following table presents the Company's total share-based compensation expense by award type:

(In thousands)Year Ended December 31,
202420232022
RSUs$20,783 $21,709 $21,048 
Performance RSUs9,375 8,857 5,589 
Options2,153 5,059 8,820 
Total Share Based Compensation Expense(1)
$32,311 $35,625 $35,457 
(1) Total share based compensation expense includes $3.7 million and $1.0 million of expense from cash settled awards for the years ended December 31, 2024 and 2023, respectively. There was no expense from cash settled awards for the year ended December 31, 2022.
Schedule of Loss Per Share
(In thousands, except per share data)Year Ended December 31,
 202420232022
NUMERATOR: 
Net loss attributable to the Company – common shares$(1,009,941)$(1,102,660)$(264,663)
DENOMINATOR(1):
 
Weighted average common shares outstanding - basic151,272 149,255 148,058 
  Stock options and restricted stock(2):
— — — 
Weighted average common shares outstanding - diluted151,272 149,255 148,058 
Net loss attributable to the Company per common share: 
Basic$(6.68)$(7.39)$(1.79)
Diluted$(6.68)$(7.39)$(1.79)

(1)All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the years ended December 31, 2024, 2023, and 2022.
(2)Outstanding equity awards representing 15.1 million, 13.6 million and 11.0 million shares of Class A common stock of the Company for the years ended December 31, 2024, 2023, and 2022, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.